Quick Heal Technologies Limited , a prominent player in the cybersecurity sector, has announced two significant employee stock-related developments. The company has granted 48,000 new employee stock options and allotted 32,205 equity shares under its Employee Stock Option Plan (ESOP) Scheme 2021. These moves are part of the company's strategy to incentivize and retain talent.

New Stock Option Grant

The Nomination and Remuneration Committee of Quick Heal Technologies has approved the grant of 48,000 employee stock options to eligible employees. The key details of this grant are:

• Exercise price: ₹151.00 per share
• Face value of shares: ₹10.00 each
• Vesting schedule: 4-year schedule with 25% vesting annually
• Exercise window: 3 years post-vesting

Allotment of Equity Shares

In addition to the new grant, the company has allotted 32,205 equity shares under its ESOP Scheme 2021. The details of this allotment are as follows:

Impact on Share Capital

Following the allotment of 32,205 shares, Quick Heal Technologies' total issued shares have increased to 5,41,90,467 equity shares. The company's total issued share capital now stands at ₹54,19,04,670.00, divided into 5,41,90,467 equity shares of ₹10.00 each.

Trading and ISIN Details

The newly allotted shares will initially be credited under a temporary ISIN IN8306L01019. Once the final trading approval is received, these shares will be transferred to the company's permanent ISIN INE306L01010. The company has confirmed that these new shares are identical in all respects to the existing equity shares.

ESOP Scheme and Corporate Strategy

Both the new grant of stock options and the allotment of shares under the ESOP Scheme 2021 underscore Quick Heal's commitment to aligning employee interests with those of the company and its shareholders. Such schemes are often implemented to motivate employees, foster a sense of ownership, and contribute to long-term value creation.

These corporate actions reflect Quick Heal Technologies' focus on employee retention and motivation, which can be crucial in the competitive cybersecurity industry where talent is a key differentiator.

Investors and market participants will be keeping a close eye on how these equity-based incentives might impact the company's stock performance and whether they translate into enhanced employee productivity and company growth in the long run.

Quick Heal Technologies Limited , a leading global cybersecurity solutions provider, has announced its financial results for the second quarter of fiscal year 2026, showcasing a robust recovery and growth across its business segments.

Financial Highlights

The company reported a significant improvement in its financial performance for Q2 FY26:

Segment Performance

Quick Heal's performance was driven by growth in both its enterprise and consumer segments:

• Enterprise Revenue: ₹36.90 crores, up 30% year-over-year
• Consumer Revenue: ₹59.50 crores, up 8.3% year-over-year

Key Developments

1. Data Privacy Management Platform: Quick Heal onboarded its first enterprise customer for the Seqrite Data Privacy Management Platform, which aids enterprises in achieving and maintaining compliance with privacy laws like the DPDP Act.

2. AI-Powered Cybersecurity: The company signed an MOU with BHASHINI to integrate Seqrite's AI-powered cybersecurity modules into India's multilingual AI platform, offering data privacy solutions in 22 languages.

3. International Expansion: Quick Heal continues to see growth in international revenue, driven by new market entries in Southeast Asia and the Middle East.

4. Awards and Recognition: Seqrite received the "Cybersecurity Service Provider of the Year" Award at the Times Secure India Summit 2025, while Quick Heal won "The Leading Cybersecurity Solutions Brand of 2025" at NCN Excellence Awards.

Management Commentary

Dr. Kailash Katkar, Chairman and Managing Director of Quick Heal Technologies Limited, commented on the results: "Q2 FY26 witnessed good performance across both verticals of our business, which is a clear reflection of the resilience and diversification of our cybersecurity portfolio through continued investments in differentiated, AI-led innovations. The consumer business has shown recovery with seasonal tailwinds, while our enterprise vertical continues to gain momentum through innovative solution offerings."

Ankit Maheshwari, Chief Financial Officer, added: "We are pleased with the revenue growth momentum this quarter. Owing to the stable cost structures, the revenue improvement enabled us to restore healthy margins. Our continued investments in R&D and S&M for market expansion are key tenets for our long-term pivot and have started to show positive traction."

Future Outlook

As Quick Heal Technologies moves into the second half of the fiscal year, the company remains focused on scaling its AI-led innovations, expanding partner ecosystems, and driving predictable growth. With a healthy order pipeline and a diversified revenue mix, Quick Heal is well-positioned to deliver sustainable shareholder value in the evolving cybersecurity landscape.

The company's strategic focus on both consumer and enterprise segments, coupled with its expansion into international markets and investment in cutting-edge technologies like AI, positions it strongly for continued growth in the global cybersecurity market.